210 related articles for article (PubMed ID: 27496969)
1. DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years.
Hubers AJ; Heideman DA; Duin S; Witte BI; de Koning HJ; Groen HJ; Prinsen CF; Bolijn AS; Wouters M; van der Meer SE; Steenbergen RD; Snijders PJ; Uyterlinde A; Berkhof H; Smit EF; Thunnissen E
J Clin Pathol; 2017 Mar; 70(3):250-254. PubMed ID: 27496969
[TBL] [Abstract][Full Text] [Related]
2. DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach.
Hubers AJ; Heideman DA; Burgers SA; Herder GJ; Sterk PJ; Rhodius RJ; Smit HJ; Krouwels F; Welling A; Witte BI; Duin S; Koning R; Comans EF; Steenbergen RD; Postmus PE; Meijer GA; Snijders PJ; Smit EF; Thunnissen E
Br J Cancer; 2015 Mar; 112(6):1105-13. PubMed ID: 25719833
[TBL] [Abstract][Full Text] [Related]
3. Combined sputum hypermethylation and eNose analysis for lung cancer diagnosis.
Hubers AJ; Brinkman P; Boksem RJ; Rhodius RJ; Witte BI; Zwinderman AH; Heideman DA; Duin S; Koning R; Steenbergen RD; Snijders PJ; Smit EF; Sterk PJ; Thunnissen E
J Clin Pathol; 2014 Aug; 67(8):707-11. PubMed ID: 24915850
[TBL] [Abstract][Full Text] [Related]
4. Methylation analysis in spontaneous sputum for lung cancer diagnosis.
Hubers AJ; van der Drift MA; Prinsen CF; Witte BI; Wang Y; Shivapurkar N; Stastny V; Bolijn AS; Hol BE; Feng Z; Dekhuijzen PN; Gazdar AF; Thunnissen E
Lung Cancer; 2014 May; 84(2):127-33. PubMed ID: 24598366
[TBL] [Abstract][Full Text] [Related]
5. Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection.
Su Y; Fang H; Jiang F
Clin Epigenetics; 2016; 8():109. PubMed ID: 27777637
[TBL] [Abstract][Full Text] [Related]
6. Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum.
Hulbert A; Jusue-Torres I; Stark A; Chen C; Rodgers K; Lee B; Griffin C; Yang A; Huang P; Wrangle J; Belinsky SA; Wang TH; Yang SC; Baylin SB; Brock MV; Herman JG
Clin Cancer Res; 2017 Apr; 23(8):1998-2005. PubMed ID: 27729459
[No Abstract] [Full Text] [Related]
7. Prolonged sampling of spontaneous sputum improves sensitivity of hypermethylation analysis for lung cancer.
Hubers AJ; Heideman DA; Herder GJ; Burgers SA; Sterk PJ; Kunst PW; Smit HJ; Postmus PE; Witte BI; Duin S; Snijders PJ; Smit EF; Thunnissen E
J Clin Pathol; 2012 Jun; 65(6):541-5. PubMed ID: 22461647
[TBL] [Abstract][Full Text] [Related]
8. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
[TBL] [Abstract][Full Text] [Related]
9. An epigenetic classifier for early stage lung cancer.
Su Y; Fang HB; Jiang F
Clin Epigenetics; 2018; 10():68. PubMed ID: 29796119
[TBL] [Abstract][Full Text] [Related]
10. Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study.
Cirincione R; Lintas C; Conte D; Mariani L; Roz L; Vignola AM; Pastorino U; Sozzi G
Int J Cancer; 2006 Mar; 118(5):1248-53. PubMed ID: 16152615
[TBL] [Abstract][Full Text] [Related]
11. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.
Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F
Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916
[TBL] [Abstract][Full Text] [Related]
12. The Indirect Efficacy Comparison of DNA Methylation in Sputum for Early Screening and Auxiliary Detection of Lung Cancer: A Meta-Analysis.
Liu D; Peng H; Sun Q; Zhao Z; Yu X; Ge S; Wang H; Fang H; Gao Q; Liu J; Wu L; Song M; Wang Y
Int J Environ Res Public Health; 2017 Jun; 14(7):. PubMed ID: 28644424
[TBL] [Abstract][Full Text] [Related]
13. Advances in sputum analysis for screening and early detection of lung cancer.
Tockman MS
Cancer Control; 2000; 7(1):19-24. PubMed ID: 10740657
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
[TBL] [Abstract][Full Text] [Related]
15. Molecular sputum analysis for the diagnosis of lung cancer.
Hubers AJ; Prinsen CF; Sozzi G; Witte BI; Thunnissen E
Br J Cancer; 2013 Aug; 109(3):530-7. PubMed ID: 23868001
[TBL] [Abstract][Full Text] [Related]
16. Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program.
Baryshnikova E; Destro A; Infante MV; Cavuto S; Cariboni U; Alloisio M; Ceresoli GL; Lutman R; Brambilla G; Chiesa G; Ravasi G; Roncalli M
Clin Cancer Res; 2008 Mar; 14(6):1913-9. PubMed ID: 18347195
[TBL] [Abstract][Full Text] [Related]
17. Methylation of RAS association domain family protein 1A as a biomarker of lung cancer.
Grote HJ; Schmiemann V; Geddert H; Bocking A; Kappes R; Gabbert HE; Sarbia M
Cancer; 2006 Apr; 108(2):129-34. PubMed ID: 16444703
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnostic markers for lung cancer in sputum and plasma.
Wang YC; Hsu HS; Chen TP; Chen JT
Ann N Y Acad Sci; 2006 Sep; 1075():179-84. PubMed ID: 17108209
[TBL] [Abstract][Full Text] [Related]
19. Automated 3-dimensional morphologic analysis of sputum specimens for lung cancer detection: Performance characteristics support use in lung cancer screening.
Wilbur DC; Meyer MG; Presley C; Aye RW; Zarogoulidis P; Johnson DW; Peled N; Nelson AC
Cancer Cytopathol; 2015 Sep; 123(9):548-56. PubMed ID: 26153135
[TBL] [Abstract][Full Text] [Related]
20. Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers.
Guzmán L; Depix MS; Salinas AM; Roldán R; Aguayo F; Silva A; Vinet R
Diagn Pathol; 2012 Jul; 7():87. PubMed ID: 22818553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
